|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
6
|
Zenith Epigenetics
|
Feb 28, 2022 09:29AM
|
|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
6
|
Zenith Epigenetics
|
Feb 26, 2022 09:22AM
|
|
Re: something to ponder
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 25, 2022 10:04AM
|
|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
2
|
Zenith Epigenetics
|
Feb 25, 2022 07:54AM
|
|
Re: Shorters have not cashed out yet!
|
1
|
Resverlogix Corp.
|
Feb 22, 2022 07:37AM
|
|
Re: Not out of the woods yet with COVID-19
|
11
|
Resverlogix Corp.
|
Feb 18, 2022 03:04PM
|
|
Not out of the woods yet with COVID-19
|
6
|
Resverlogix Corp.
|
Feb 18, 2022 07:48AM
|
|
Re: Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
2
|
Resverlogix Corp.
|
Feb 17, 2022 07:59AM
|
|
Re: Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
1
|
Resverlogix Corp.
|
Feb 17, 2022 07:33AM
|
|
Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
8
|
Resverlogix Corp.
|
Feb 17, 2022 07:19AM
|
|
Re: Hello
|
5
|
Resverlogix Corp.
|
Feb 16, 2022 03:41PM
|
|
Re: Epigenetics
|
3
|
Resverlogix Corp.
|
Feb 14, 2022 06:07AM
|
|
Re: a new study that one researcher called "stunning."
|
3
|
Resverlogix Corp.
|
Feb 11, 2022 11:15AM
|
|
Re: a new study that one researcher called "stunning."
|
8
|
Resverlogix Corp.
|
Feb 11, 2022 09:18AM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
2
|
Zenith Epigenetics
|
Feb 11, 2022 08:52AM
|
|
Shorters have not cashed out yet!
|
3
|
Resverlogix Corp.
|
Feb 10, 2022 11:11AM
|
|
Warrants back in favour?
|
2
|
Resverlogix Corp.
|
Feb 10, 2022 10:30AM
|
|
Re: wasn't expecting to much of a response - here it is..
|
5
|
Resverlogix Corp.
|
Feb 09, 2022 08:12AM
|
|
Re: How does a person get enrolled in the rvx covid study
|
2
|
Resverlogix Corp.
|
Feb 09, 2022 07:21AM
|
|
Re: Major Investors
|
2
|
Resverlogix Corp.
|
Feb 07, 2022 06:29AM
|
